The impact of hepatitis B core antibody levels on HBV reactivation after allogeneic hematopoietic SCT: an 11-year experience at a single center

被引：11
作者：
Bae, S. K. [1 ]
Gushima, T. [1 ]
Saito, N. [2 ]
Yamanaka, I. [2 ]
Shimokawa, T. [2 ]
Matsuo, Y. [2 ]
Yoshida, S. [2 ]
Kawano, I. [2 ]
Henzan, H. [2 ]
Shimoda, S. [3 ]
Eto, T. [2 ]
Takahashi, K. [1 ]
机构：
[1] Hamanomachi Hosp, Ctr Liver Dis, Fukuoka, Japan
[2] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[3] Kyushu Univ, Med & Biosyst Sci, Fukuoka, Japan
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 11期
关键词：
VERSUS-HOST-DISEASE; TREATMENT RESPONSE; VIRUS INFECTION; TRANSPLANTATION; SEROCONVERSION; PEGINTERFERON; ANTIGEN;
D O I：
10.1038/bmt.2016.149
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1496 / 1498
页数：3
相关论文
共 15 条
[1]   Immunopathogenesis of hepatitis B virus infection [J].
Chang, J. Judy ;
Lewin, Sharon R. .
IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (01) :16-23
[2]  
Dhédin N, 1998, TRANSPLANTATION, V66, P616
[3]   Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues [J].
Fan, Rong ;
Sun, Jian ;
Yuan, Quan ;
Xie, Qing ;
Bai, Xuefan ;
Ning, Qin ;
Cheng, Jun ;
Yu, Yanyan ;
Niu, Junqi ;
Shi, Guangfeng ;
Wang, Hao ;
Tan, Deming ;
Wan, Mobin ;
Chen, Shijun ;
Xu, Min ;
Chen, Xinyue ;
Tang, Hong ;
Sheng, Jifang ;
Lu, Fengmin ;
Jia, Jidong ;
Zhuang, Hui ;
Xia, Ningshao ;
Hou, Jinlin .
GUT, 2016, 65 (02) :313-320
[4]  
Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]
[5]   National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report [J].
Filipovich, AH ;
Weisdorf, D ;
Pavletic, S ;
Socie, G ;
Wingard, JR ;
Lee, SJ ;
Martin, P ;
Chien, J ;
Przepiorka, D ;
Couriel, D ;
Cowen, EW ;
Dinndorf, P ;
Farrell, A ;
Hartzman, R ;
Henslee-Downey, J ;
Jacobsohn, D ;
McDonald, G ;
Mittleman, B ;
Rizzo, JD ;
Robinson, M ;
Schubert, M ;
Schultz, K ;
Shulman, H ;
Turner, M ;
Vogelsang, G ;
Flowers, MED .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) :945-956
[6]   Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation [J].
Hammond, Sarah P. ;
Borchelt, Anne Marie ;
Ukomadu, Chinweike ;
Ho, Vincent T. ;
Baden, Lindsey R. ;
Marty, Francisco M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) :1049-1059
[7]   ANTIBODY TO HEPATITIS B CORE ANTIGEN - SENSITIVE INDICATOR OF HEPATITIS B VIRUS REPLICATION [J].
HOOFNAGLE, JH ;
GERETY, RJ ;
NI, LY ;
BARKER, LF .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (24) :1336-1340
[8]   Quantitative Hepatitis B Core Antibody Level Is a New Predictor for Treatment Response In HBeAg-positive Chronic Hepatitis B Patients Receiving Peginterferon [J].
Hou, Feng-Qin ;
Song, Liu-Wei ;
Yuan, Quan ;
Fang, Lin-Lin ;
Ge, Sheng-Xiang ;
Zhang, Jun ;
Sheng, Ji-Fang ;
Xie, Dong-Ying ;
Shang, Jia ;
Wu, Shu-Huan ;
Sun, Yong-Tao ;
Wei, Shao-Feng ;
Wang, Mao-Rong ;
Wan, Mo-Bin ;
Jia, Ji-Dong ;
Luo, Guang-Han ;
Tang, Hong ;
Li, Shu-Chen ;
Niu, Jun-Qi ;
Zhou, Wei-dong ;
Sun, Li ;
Xia, Ning-Shao ;
Wang, Gui-Qiang .
THERANOSTICS, 2015, 5 (03) :218-226
[9]   Management of patients with hepatitis B who require immunosuppressive therapy [J].
Hwang, Jessica P. ;
Lok, Anna S-F .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2014, 11 (04) :209-219
[10]   Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation [J].
Knöll, A ;
Boehm, S ;
Hahn, J ;
Holler, E ;
Jilg, W .
BONE MARROW TRANSPLANTATION, 2004, 33 (09) :925-929
12